Correlation Between Novacyt and Europlasma
Can any of the company-specific risk be diversified away by investing in both Novacyt and Europlasma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novacyt and Europlasma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novacyt and Europlasma SA, you can compare the effects of market volatilities on Novacyt and Europlasma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novacyt with a short position of Europlasma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novacyt and Europlasma.
Diversification Opportunities for Novacyt and Europlasma
0.89 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Novacyt and Europlasma is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Novacyt and Europlasma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Europlasma SA and Novacyt is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novacyt are associated (or correlated) with Europlasma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Europlasma SA has no effect on the direction of Novacyt i.e., Novacyt and Europlasma go up and down completely randomly.
Pair Corralation between Novacyt and Europlasma
Assuming the 90 days trading horizon Novacyt is expected to generate 0.93 times more return on investment than Europlasma. However, Novacyt is 1.07 times less risky than Europlasma. It trades about -0.15 of its potential returns per unit of risk. Europlasma SA is currently generating about -0.82 per unit of risk. If you would invest 69.00 in Novacyt on August 24, 2024 and sell it today you would lose (11.00) from holding Novacyt or give up 15.94% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 95.65% |
| Values | Daily Returns |
Novacyt vs. Europlasma SA
Performance |
| Timeline |
| Novacyt |
| Europlasma SA |
Novacyt and Europlasma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Novacyt and Europlasma
The main advantage of trading using opposite Novacyt and Europlasma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novacyt position performs unexpectedly, Europlasma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Europlasma will offset losses from the drop in Europlasma's long position.| Novacyt vs. Biomerieux SA | Novacyt vs. Eurofins Scientific SE | Novacyt vs. Sartorius Stedim Biotech | Novacyt vs. SEB SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |